Search Results - "Canter, C."

A Risk‐Prediction Model for In‐Hospital Mortality After Heart Transplantation in US Children by Almond, C. S., Gauvreau, K., Canter, C. E., Rajagopal, S. K., Piercey, G. E., Singh, T. P.

“…We sought to develop and validate a quantitative risk‐prediction model for predicting the risk of posttransplant in‐hospital mortality in pediatric heart…”
Get full text

The Effects of Center Volume on Mortality in Pediatric Heart Transplantation—The Rest of the Story by Canter, C. E.

“…In pediatric heart transplantation, waitlist mortality is affected by center volume more than posttransplant mortality, and it may be an important additional…”
Get full text

Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC‐04 multi‐institutional study by Webber, S., Zeevi, A., Mason, K., Addonizio, L., Blume, E., Dipchand, A., Shaddy, R., Feingold, B., Canter, C., Hsu, D., Mahle, W., Armstrong, B., Morrison, Y., Ikle, D., Diop, H., Odim, J.

“…Sensitization is common in pediatric heart transplant candidates and waitlist mortality is high. Transplantation across a positive crossmatch may reduce wait…”
Get full text

Outpatient Management of Intra‐Corporeal Left Ventricular Assist Device System in Children: A Multi‐Center Experience by Schweiger, M., Vanderpluym, C., Jeewa, A., Canter, C. E., Jansz, P., Parrino, P. E., Miera, O., Schmitto, J., Mehegan, M., Adachi, I., Hübler, M., Zimpfer, D.

“…Little is known about the outcomes of children supported on intracorporeal left ventricular assist device (HVAD), and the feasibility of outpatient management…”
Get full text

Outcome of listing for cardiac transplantation for failed fontan : A multi-institutional study by BERNSTEIN, D, NAFTEL, D, CHIN, C, ADDONIZIO, L. J, GAMBERG, P, BLUME, E. D, HSU, D, CANTER, C. E, KIRKLIN, J. K, MORROW, W. R

“…The Fontan procedure is a successful palliation for children with single-ventricle physiology; however, many will eventually require heart transplantation. The…”
Get full text

Transplanting Hearts in the Highly Sensitized Pediatric Candidate: What's a Program to Do? by Canter, C. E.

“…Determining the best course in sensitized pediatric heart transplant candidates remains unclear with the evolution of newer techniques for qualitative,…”
Get full text

Incidence, characterization, and impact of newly detected donor‐specific anti‐HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC‐04 study by Dipchand, A. I., Webber, S., Mason, K., Feingold, B., Bentlejewski, C., Mahle, W. T., Shaddy, R., Canter, C., Blume, E. D., Lamour, J., Zuckerman, W., Diop, H., Morrison, Y., Armstrong, B., Ikle, D., Odim, J., Zeevi, A.

“…Data on the clinical importance of newly detected donor‐specific anti‐HLA antibodies (ndDSAs) after pediatric heart transplantation are lacking despite…”
Get full text

Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II by Ellison, M, Mangiola, M, Marrari, M, Bentlejewski, C, Sadowski, J, Zern, D, Kramer, Cynthia Silvia Maria, Heidt, S, Niemann, M, Xu, Q, Dipchand, A I, Mahle, W T, Rossano, J W, Canter, C E, Singh, T P, Zuckerman, W A, Hsu, D T, Feingold, B, Webber, S A, Zeevi, A

“…Human leukocyte antigen (HLA) molecular mismatch is a powerful biomarker of rejection. Few studies have explored its use in assessing rejection risk in heart…”
Get full text

The Influence of Race and Common Genetic Variations on Outcomes After Pediatric Heart Transplantation by Green, D. J., Brooks, M. M., Burckart, G. J., Chinnock, R. E., Canter, C., Addonizio, L. J., Bernstein, D., Kirklin, J. K., Naftel, D. C., Girnita, D. M., Zeevi, A., Webber, S. A.

“…Significant racial disparity remains in the incidence of unfavorable outcomes following heart transplantation. We sought to determine which pediatric…”
Get full text

Treatment and Pattern of Resolution of Antibody-Mediated Rejection with Hemodynamic Compromise Resistant to Standard Therapy after Heart Transplantation with a Positive Virtual Crossmatch by Mokshagundam, D., Castleberry, C.D., Simpson, K.E., Ybarra, A.M., Scheel, J.N., Canter, C.E.

“…Antibody-mediated rejection (AMR) with hemodynamic compromise (HC, heart failure requiring inotropic support) after heart transplantation (HT) confers a…”
Get full text

Early Neurologic Outcomes after Pediatric Heart Transplantation by Cammock, C, Castleberry, C, Choudhry, S, Simpson, K, Canter, C

Get full text

Primary Graft Dysfunction After Pediatric Heart Transplant: A Single Center Experience by Mowers, K, Simpson, K, Eghtesady, P, Petrucci, O, Canter, C, Castleberry, C

Get full text

Distinct Disease Mechanisms Govern the Progression of Pediatric and Adult Dilated Cardiomyopathy by Patel, M, Schneider, C, Mohan, J, Canter, C, Jeffrey, T, Lavine, K.J

Get full text

Heart Retransplantation by Johnson, M. R., Aaronson, K. D., Canter, C. E., Kirklin, J. K., Mancini, D. M., Mehra, M. R., Radovancevic, B., Taylor, D. O., Webber, S. A.

“…Retransplants comprise only a small minority (3–4%) of heart transplants, however outcome following retransplantation is compromised. Risk factors for a poor…”
Get full text

Mechanical Circulatory Support as a Bridge to Transplantation in Children with Single Ventricle Physiology: A Multicenter Study by Das, B.B, Kirklin, J, Pruitt, E, Chrisant, M, Lin, K, Hong, B, Daneman, S, Canter, C

Get full text

Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study by Chrisant, M R K, Naftel, D C, Drummond-Webb, J, Chinnock, R, Canter, C E, Boucek, M M, Boucek, R J, Hallowell, S C, Kirklin, J K, Morrow, W R

“…Infants with hypoplastic left heart syndrome (HLHS) commonly undergo cardiac transplantation as primary management. We examined outcomes of primary…”
Get more information

Post-Transplant Outcomes of Patients Supported with the Berlin Heart EXCOR as a Bridge to Transplantation: A Multi-Institutional Study by Jeewa, A, Imamura, M, Canter, C, Niebler, R, VanderPluym, C, Rosenthal, D, Kirklin, J.K, Tresler, M, McMullan, M, Morell, V, Turrentine, M, Ameduri, R, Nguyen, K, Kanter, K, Conway, J, Gajarski, R, Fraser, C.D

Get full text

Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year After Pediatric Heart Transplantation by Dipchand, A.I, Webber, S, Much, K, Feingold, B, Bentlejewski, C, Blume, E.D, Shaddy, R, Canter, C, Lamour, J, Mahle, W, Zuckerman, W, Diop, H, Morrison, Y, Armstrong, B, Ikle, D, Odim, J, Zeevi, A

Get full text

Berlin Heart Post Approval Outcomes in North America by Jaquiss, R.D, Fraser, C.D, Rosenthal, D.N, Humpl, T, Canter, C, Morales, D.L, Tjossem, C, Kroslowitz, R

Get full text

A multicenter study of primary graft failure after infant heart transplantation: Impact of extracorporeal membrane oxygenation on outcomes by Kaushal, S., Matthews, K. L., Garcia, X., Wehman, B., Riddle, E., Ying, Z., Nubani, R., Canter, C. E., Morrow, W. R., Huddleston, C. B., Backer, C. L., Pahl, E.

“…Primary graft failure is the major cause of mortality in infant HTx. The aim of this study was to characterize the indication and outcomes of infants requiring…”
Get full text